Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer

Expression and Prognostic Significance of CD47–SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer

(2021) Akane Sugimura-Nagata et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Clinical significance of signal regulatory protein alpha (SIRPα) expression in esophageal squamous cell carcinoma

(2021) Naomichi Koga et al.   CANCER SCIENCE

Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: correlation with regulatory FOXP3+T-cell tumour stroma infiltration

(2020) Alexandra Giatromanolaki et al.   BRITISH JOURNAL OF CANCER

Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer

(2020) Oscar Arrieta et al.   Cancer Medicine

Combination of CD47 and SIRPα constituting the "don't eat me signal" is a prognostic factor in diffuse large B‐cell lymphoma

(2020) Ryo Kazama et al.   CANCER SCIENCE

Just eat it: A review of CD47 and SIRP-α antagonism

(2020) Bryan Oronsky et al.   SEMINARS IN ONCOLOGY

Clinicopathological analysis of immunohistochemical expression of CD47 and SIRPα in adult T‐cell leukemia/lymphoma

(2020) Eriko Yanagida et al.   HEMATOLOGICAL ONCOLOGY

Clinicopathological significance of CD47 expression in hepatocellular carcinoma

(2020) Hyunsung Kim et al.   JOURNAL OF CLINICAL PATHOLOGY

Cancer immunotherapy comes of age and looks for maturity

(2020) Amanda Finck et al.   Nature Communications

Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer

(2020) Yan Xu et al.   ESMO Open

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma

(2019) Jian‐Hua Wang et al.   Cancer Medicine

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

(2019) Branimir I. Sikic et al.   JOURNAL OF CLINICAL ONCOLOGY

Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis

(2019) Alexandra Giatromanolaki et al.   MEDICAL ONCOLOGY

High expression of CD47 in triple negative breast cancer is associated with epithelial‑mesenchymal transition and poor prognosis

(2019) Jingping Yuan et al.   Oncology Letters

PD-L1 and CD47 co-expression in pulmonary sarcomatoid carcinoma: a predictor of poor prognosis and potential targets of future combined immunotherapy

(2019) Zhenlin Yang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint

(2019) Erik Voets et al.   Journal for ImmunoTherapy of Cancer

CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+/Foxp3+ T cells

(2018) Hiroyuki Abe et al.   VIRCHOWS ARCHIV

Significance of CD47 expression in gastric cancer

(2017) Tomoya Sudo et al.   Oncology Letters

The CD47-SIRP  signalling system: its physiological roles and therapeutic application

(2014) Y. Murata et al.   JOURNAL OF BIOCHEMISTRY

Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response

(2013) D. Tseng et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA